Atopic Dermatitis (AD)
What is it? Atopic dermatitis is the most common type of eczema, a skin condition that makes you itch and leaves red blotches, usually on your face, arms, trunk and legs. The rashes tend to flare from different triggers and can settle down, but then come back again.
Current available trials:
- Age 18 to 75 years old.
- Moderate to severe atopic dermatitis with onset of symptoms at least 1 year prior.
- History of inadequate response to treatment with topical corticosteroids, or topical calcineurin inhibitors (TCI), or for whom topical treatments are otherwise medically inadvisable.
- Requirements: intermittent blood collection, ECG, and physical examinations.
- Injection every 2 weeks, 16 weeks long, free medications and evaluations, with compensation included.
- Must be able to remain compliant with all study activities.
Current available trials:
- Male or female between the ages of 2 to 85 years old.
- Willing to answer questions regarding living with your condition and standard of care medications.
- Skin scraping is obtained at every study visit.
- Compensation will be given at each study visit.
Current available trials:
- Males or females 18 years of age and older.
- Willing to answer survey questions regarding living with your condition and standard of care medications.
- Compensation will be given at each registry visit.
- Registry visits are every 6 months or shorter if a medication change is required by your doctor.
Current available trials:
- Pediatric population who are being treated for atopic dermatitis.
- Data will be collected during at least 12 visits that will happen over a 5-year period.
- Willing to answer survey questions regarding living with your/your child’s condition and standard of care medications.
- Compensation will be given at each registry visit.